The Spectacular 770% Surge of a Biotech Stock in Just 12 Weeks

(Bloomberg) -- A Korean biotechnology stock has surged more than 700% since August as investors looked beyond an earlier failed clinical study in favor of the prospect of its cancer drugs reaching ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.